Arora Medi Lines Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 16-11-2024
- Paid Up Capital ₹ 4.50 M
as on 16-11-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 39.60 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.94 Cr
as on 16-11-2024
- Revenue 83.65%
(FY 2023)
- Profit 18.15%
(FY 2023)
- Ebitda 98.55%
(FY 2023)
- Net Worth 19.90%
(FY 2023)
- Total Assets 57.11%
(FY 2023)
About Arora Medi Lines
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹39.60 Cr. The company has closed loans amounting to ₹5.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Arora, Bikash Ghosh, Aditya Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397UP1993PTC041201
- Company No.
041201
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arora Medi Lines?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Arora  | Director | 18-Aug-2003 | Current |
| Bikash Ghosh | Director | 02-Jun-1998 | Current |
| Aditya Arora | Director | 25-Feb-2019 | Current |
| Siddharth Arora | Director | 25-Feb-2019 | Current |
Financial Performance of Arora Medi Lines.
Arora Medi Lines Pvt. Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 83.65% increase. The company also saw a substantial improvement in profitability, with a 18.15% increase in profit. The company's net worth Soared by an impressive increase of 19.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arora Medi Lines?
In 2023, Arora Medi Lines had a promoter holding of 41.00% and a public holding of 59.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Aug 2024 | ₹18.00 Cr | Open |
Standard Chartered Bank Creation Date: 26 Jul 2024 | ₹16.00 Cr | Open |
Axis Bank Limited Creation Date: 29 Nov 2023 | ₹3.50 M | Open |
How Many Employees Work at Arora Medi Lines?
Unlock and access historical data on people associated with Arora Medi Lines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arora Medi Lines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arora Medi Lines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
